Erlanger Health System

Forma Medical Launches OptimalHT the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure After 50+ Procedures

Retrieved on: 
Wednesday, September 6, 2023

Forma Medical , an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s first instrumented Minimally Invasive Surgery (MIS) Hammertoe Arthrodesis procedure, that has treated more than 50 hammertoe deformities.

Key Points: 
  • Forma Medical , an emerging innovator in medical device technologies, announces today the launch of OptimalHT, the world’s first instrumented Minimally Invasive Surgery (MIS) Hammertoe Arthrodesis procedure, that has treated more than 50 hammertoe deformities.
  • “It’s no secret that minimally invasive surgery is the future of Foot and Ankle care,” said Dr. Noman Siddiqui, DPM, LifeBridge Health, Baltimore.
  • “Receiving our first FDA approval and launching the OptimalHT system represents a pivotal moment for Forma Medical,” said James Gault, Vice President of Forma Medical.
  • For more information about Forma Medical and to learn about the company’s groundbreaking procedures, please visit www.formamedical.com or www.MIShammertoe.com .

Imperative Care Announces FDA Clearance of Zoom 88 Support, Designed to Bring the Benefits of Intracranial Access to More Stroke Patients

Retrieved on: 
Tuesday, July 25, 2023

Imperative Care has pioneered the use of large-bore .088” intracranial access paired with angled-tip aspiration catheters to enable better and faster reperfusion for stroke procedures.1,2 Zoom 88 Support expands the company’s .088” intracranial access portfolio – the only access portfolio on the market to enable large-bore intracranial access.

Key Points: 
  • Imperative Care has pioneered the use of large-bore .088” intracranial access paired with angled-tip aspiration catheters to enable better and faster reperfusion for stroke procedures.1,2 Zoom 88 Support expands the company’s .088” intracranial access portfolio – the only access portfolio on the market to enable large-bore intracranial access.
  • The portfolio also includes the existing Zoom 88 LDP and the Zoom RDL Access Platform.
  • Zoom 88 Support provides the same benefits of intracranial access found with Zoom 88 LDP, with the ability to treat more proximal or tandem occlusions,” said Ariel Sutton, GM of Imperative Care’s Stroke business.
  • “With products like Zoom 88 Support, Imperative Care continues to respond to the needs of patients with much-needed solutions to help streamline stroke procedures and treat patients quickly and effectively.”

Realty Trust Group Partners with Hamilton Health Care System on New Cardiovascular Pavilion

Retrieved on: 
Tuesday, July 18, 2023

KNOXVILLE, Tenn., July 18, 2023 /PRNewswire/ -- Realty Trust Group (RTG) has been selected to provide program management services for the recently announced Cardiovascular Pavilion to be constructed on the main campus of Hamilton Medical Center in Dalton, Georgia.

Key Points: 
  • KNOXVILLE, Tenn., July 18, 2023 /PRNewswire/ -- Realty Trust Group (RTG) has been selected to provide program management services for the recently announced Cardiovascular Pavilion to be constructed on the main campus of Hamilton Medical Center in Dalton, Georgia.
  • The 175,000-square-foot expansion will offer a broad range of services, spanning cardiovascular surgery, electrophysiology, interventional cardiology, and structural cardiology.
  • In a statement from Jeff Myers, President and Chief Executive Officer for Hamilton Health Care System, commented, "The Health System has been known for bringing innovation to this region, including open heart surgery and advanced cardiovascular care.
  • Hamilton Health Care System is a not for-for-profit, fully integrated system of care serving the northwest Georgia region.

Axis Research & Technologies Appoints Dr. Mark G. Freeman as Chief Medical Advisor

Retrieved on: 
Thursday, March 2, 2023

IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Axis Research & Technologies , a premier bioskills training and cadaver lab supporting medical device research and training, is proud to introduce Dr. Mark G. Freeman as the company’s Chief Medical Advisor.

Key Points: 
  • IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Axis Research & Technologies , a premier bioskills training and cadaver lab supporting medical device research and training, is proud to introduce Dr. Mark G. Freeman as the company’s Chief Medical Advisor.
  • Dr. Freeman has built a strong reputation for excellence with his ability to manage complex conditions including primary and revision surgeries, fractures, and musculoskeletal infections.
  • “Axis is very fortunate to be working with Dr. Freeman,” said Nick Moran, CEO of Axis.
  • “As Chief Medical Advisor for Axis, I am proud to assist healthcare clients by offering them insights into how they can best optimize their labs and training experiences at Axis facilities.”
    For more information about Axis Research & Technology, please visit axisrt.com .

ApolloMD Expands Leadership as Company Growth Continues

Retrieved on: 
Monday, February 27, 2023

ATLANTA, Feb. 27, 2023 /PRNewswire/ -- ApolloMD's robust growth calls for the extension of clinical leadership roles to champion our dynamic teams in the form of Regional Vice Presidents (RVPs). RVPs are clinical leaders managing a roster of facilities while supporting company operations in other areas. These leaders will work closely with the Regional and Divisional Presidents, and the operations support assigned to the geographic region.

Key Points: 
  • "The need for this added clinical leadership support has become evident as we continue to grow and develop more partnerships," says Yogin Patel, ApolloMD President.
  • Meet the new ApolloMD Regional Vice Presidents:
    Dr. Richard T. Benson II joined ApolloMD in 2017 and immediately proved to be a dynamic leader with an inspirational vision and a knack for developing team unity.
  • As RVP, Dr. Benson approaches this role with that same enthusiasm and continues his mission in service, now on a systems level.
  • He believes that integrating the priorities of medical staff leadership and emergency medicine leadership can prove to be a vital element of success.

$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders

Retrieved on: 
Tuesday, February 7, 2023

PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- A $25 million gift from an anonymous donor to Penn Medicine and Children's Hospital of Philadelphia (CHOP) will establish the Center for Epilepsy and Neurodevelopmental Disorders (ENDD), accelerating collaborative research in genetic therapies for neurodevelopmental disorders.

Key Points: 
  • PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- A $25 million gift from an anonymous donor to Penn Medicine and Children's Hospital of Philadelphia (CHOP) will establish the Center for Epilepsy and Neurodevelopmental Disorders (ENDD), accelerating collaborative research in genetic therapies for neurodevelopmental disorders.
  • "This important gift will accelerate the progress of an extraordinary partnership between Penn and CHOP that demonstrates the power of collaboration and a commitment to finding cures.
  • "CHOP and Penn have systematically invested in integrated care programs for genetic epilepsies and neurodevelopmental disorders.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/25-million-gift-to-penn-medicin...
    SOURCE Children's Hospital of Philadelphia; University of Pennsylvania School of Medicine

Clinical Trials Network of Tennessee expands statewide network, providing innovative care for patients and delivering impact across Tennessee

Retrieved on: 
Friday, December 23, 2022

MEMPHIS, Tenn., Dec. 23, 2022 (GLOBE NEWSWIRE) -- The Clinical Trials Network of Tennessee (CTN2) supports innovation in healthcare for the citizens of Tennessee by implementing industry-sponsored research from the University of Tennessee Health Science Center (UTHSC) in 87 current clinical trials across the state.

Key Points: 
  • MEMPHIS, Tenn., Dec. 23, 2022 (GLOBE NEWSWIRE) -- The Clinical Trials Network of Tennessee (CTN2) supports innovation in healthcare for the citizens of Tennessee by implementing industry-sponsored research from the University of Tennessee Health Science Center (UTHSC) in 87 current clinical trials across the state.
  • In fiscal year 2022, CTN2 exceeded its goal of $8 million in contract dollars to report a total of over $9.7 million.
  • These partnership sites provide the EDW with over 3.58 million patients across Tennessee, representing over 50% of the state’s population.
  • Additionally, CTN2 expects to accrue over $12 million in clinical trial contract value to the University of Tennessee and UTHSC.

The Group Savings Organization Expands Board of Advisors with Three Nationally Renowned Healthcare Business Leaders

Retrieved on: 
Wednesday, September 28, 2022

The Group Saving Organization (The GSO) announced today that it has appointed three new members to its board of advisors.

Key Points: 
  • The Group Saving Organization (The GSO) announced today that it has appointed three new members to its board of advisors.
  • Moore has held leadership positions for some of the nations most respected healthcare organizations, including Mercy Healthcare, Baxter International, Cardinal Health, and the healthcare division of the UPS Logistics Group.
  • Ann Pumpian Former Senior Vice President and Chief Financial Officer for Sharp HealthCare in San Diego.
  • Pumpian also serves on the Sharp Health Plan Board and the State of California's Department of Managed Health Care Financial Solvency Standards Board.

DispatchHealth and Marshfield Clinic Health System Announce Partnership to Bring In-Home Acute Care to Wisconsin

Retrieved on: 
Tuesday, July 12, 2022

DENVER and MARSHFIELD, Wis., July 12, 2022 /PRNewswire/ -- DispatchHealth , the nation's first comprehensive in-home medical care provider, and Marshfield Clinic Health System, one of the country's largest rural health care systems, today announced their partnership to bring patients on-demand, in-home medical care.

Key Points: 
  • DENVER and MARSHFIELD, Wis., July 12, 2022 /PRNewswire/ -- DispatchHealth , the nation's first comprehensive in-home medical care provider, and Marshfield Clinic Health System, one of the country's largest rural health care systems, today announced their partnership to bring patients on-demand, in-home medical care.
  • According to Marshfield Clinic Health System CEO Dr. Susan Turney, the Health System's partnership with DispatchHealth is another example of how Marshfield serves the rural patient population through a variety of alternative care delivery methods.
  • Marshfield Clinic Health System is an integrated health system whose mission is to enrich lives through accessible, affordable compassionate health care.
  • Primary operations include more than 60 Marshfield Clinic locations, 11 hospitals, Marshfield Children's Hospital, Marshfield Clinic Research Institute, Security Health Plan and Marshfield Clinic Health System Foundation.Learn more at marshfieldclinic.org .

Grant Cardone's 10X Health System Opens Its First Location in Aventura, Florida

Retrieved on: 
Thursday, April 28, 2022

AVENTURA, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- 10X Health System opens the doors to its very first location in Aventura, Florida, offering South Floridians a chance to optimize their body, mind, and wellness.

Key Points: 
  • AVENTURA, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- 10X Health System opens the doors to its very first location in Aventura, Florida, offering South Floridians a chance to optimize their body, mind, and wellness.
  • 10X Health System utilizes an integrative treatment approach provided by a team of top medical experts.
  • With decades of experience, 10X Health System plans to open centers across the United States, which will offer a truly unforgettable well-being experience.
  • About 10X Health System: Because they're interested in treating the person and not the symptom, their results speak for themselves.